Liver Fibrosis

Naltrexone, an opioid receptor antagonist, attenuates liver fibrosis in bile duct ligated rats
M R Ebrahimkhani, S Kiani, F Oakley, T Kendall, A Shariftabrizi, S M Tavangar, L Moezi, S Payabvash, A Karoon, H Hoseininik, D A Mann, K P Moore, A R Mani, A R Dehpour

Gut Nov 2006, 55 (11) 1606-1616; DOI: 10.1136/gut.2005.076778
A pilot study in patients with established advanced liver fibrosis using pirfenidone
J Armendáriz-Borunda, M C Islas-Carbajal, E Meza-García, A R Rincón, S Lucano, A S Sandoval, A Salazar, J Berumen, A Alvarez, A Covarrubias, G Aréchiga, L García

Gut Nov 2006, 55 (11) 1663-1665; DOI: 10.1136/gut.2006.107136
Regulation of E-box DNA binding during in vivo and in vitro activation of rat and human hepatic stellate cells
K J Vincent, E Jones, M J P Arthur, D E Smart, J Trim, M C Wright, D A Mann

Gut Nov 2001, 49 (5) 713-719; DOI: 10.1136/gut.49.5.713
Quantifying and monitoring fibrosis in non-alcoholic fatty liver disease using dual-photon microscopy
Yan Wang, Grace Lai-Hung Wong, Fang-Ping He, Jian Sun, Anthony Wing-Hung Chan, Jinlian Yang, Sally She-Ting Shu, Xieer Liang, Yee Kit Tse, Xiao-Tang Fan, Jinlin Hou, Henry Lik-Yuen Chan, Vincent Wai-Sun Wong

Gut Jun 2020, 69 (6) 1116-1126; DOI: 10.1136/gutjnl-2019-318841
Assessment of liver fibrosis with the gamma-glutamyl transpeptidase to platelet ratio: a multicentre validation in patients with HBV infection
Xiao-Jie Lu, Xiu-Hui Li, Zhao-Xin Yuan, Hai-Ying Sun, Xiao-Chen Wang, Xiaolong Qi, Xin Zhang, Beicheng Sun

Gut Oct 2018, 67 (10) 1903-1904; DOI: 10.1136/gutjnl-2017-315299
The HLF/IL-6/STAT3 feedforward circuit drives hepatic stellate cell activation to promote liver fibrosis
Dai-Min Xiang, Wen Sun, Bei-Fang Ning, Teng-Fei Zhou, Xiao-Feng Li, Wei Zhong, Zhuo Cheng, Ming-Yang Xia, Xue Wang, Xing Deng, Wei Wang, Heng-Yu Li, Xiu-Liang Cui, Shi-Chao Li, Bin Wu, Wei-Fen Xie, Hong-Yang Wang, Jin Ding

Gut Sep 2018, 67 (9) 1704-1715; DOI: 10.1136/gutjnl-2016-313392
OC-007 Enhancing detection and treatment of viral hepatitis and liver fibrosis in vulnerable and homeless adults through dedicated hostel-based liver service: valid (vulnerable adults liver disease) study
A Hashim, L Macken, T Worthley, GP Aithal, S Verma

Gut Jul 2017, 66 (Suppl 2) A4; DOI: 10.1136/gutjnl-2017-314472.7
PWE-098 Risk stratification and non-invasive monitoring of patients with parenteral nutrition associated liver disease
D Mansour, L Gemell, C Byrne, S Masson, M Bannon, C Mountford, H Leyland, N Thompson

Gut Jul 2017, 66 (Suppl 2) A176-A177; DOI: 10.1136/gutjnl-2017-314472.344
PTU-102 Acute decompensated liver cirrhosis: are we bundling or bungling: our data from 2014 and 2016
O Adeloye, T Butler, K Patel, E Donaldson

Gut Jul 2017, 66 (Suppl 2) A101-A102; DOI: 10.1136/gutjnl-2017-314472.197
PTU-094 A novel paeonol derivative inhibits hepatic stellate cells activation and liver fibrosis by blocking tgf-Β1/smad and pdgf-bb/mapk signalling pathways
Y-H Wang, Y-J Liao

Gut Jul 2017, 66 (Suppl 2) A98; DOI: 10.1136/gutjnl-2017-314472.190

Main menu

Liver Fibrosis

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Liver Fibrosis

Pages